Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel augmentation for refractory PTSD in veterans
NCT00292370Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of quetiapine in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Primary endpoint: Clinician-Administered PTSD Scale at 16 weeks. Started Jan 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00292370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292370.